Impairment and Valuation Loss on Investment Securities Due to Share Price Decline
First written in FY2016. 8 of 16 entries say "Restated". Latest entry: FY2022.
The whole theme swung hardest in 2019: 54 of 136 companies on the "Worse" side.
- FY2022MaterialisedAnnual report
「During the consolidated fiscal year, we recognized impairment losses and recorded a ¥6 million valuation loss on investment securities.」
The risk of changes in the market prices of investment securities materialized again during the fiscal year through the recognition of a ¥6 million valuation loss on investment securities. - FY2022-Q3MaterialisedAnnual report
「Valuation loss on investment securities 107 28」
A ¥28 million valuation loss on investment securities was recorded during the first nine months of the fiscal year, demonstrating that the risk of valuation losses due to falling share prices and other factors continued to materialize. - FY2022-Q1MaterialisedAnnual report
「Valuation loss on investment securities 29」
A ¥29 million valuation loss on investment securities was recorded during the first quarter, demonstrating that the risk of valuation losses due to falling share prices and other factors materialized. - FY2021-Q3MaterialisedAnnual report
「Valuation loss on investment securities - 107」
A ¥107 million valuation loss on investment securities was recorded during the first nine months of the fiscal year, demonstrating that the risk of valuation losses due to falling share prices and other factors materialized. - FY2021-Q2MaterialisedAnnual report
「Valuation loss on investment securities 69」
A ¥69 million valuation loss on investment securities was recorded during the first six months of the fiscal year, demonstrating that the risk of valuation losses due to falling share prices and other factors materialized. - FY2021-Q1MaterialisedAnnual report
「Valuation loss on investment securities 62」
A ¥62 million valuation loss on investment securities was recorded in the first quarter, demonstrating that the risk of impairment and valuation losses due to falling share prices materialized again. - FY2020-Q3RestatedAnnual report
「If broad-based and substantial declines in share prices continue, impairment or valuation losses may arise on investment securities held, affecting our group's performance and potentially reducing its equity ratio.」
The risk of impairment and valuation losses on investment securities held due to falling share prices continues. - FY2020-Q2RestatedAnnual report
「If broad-based and substantial declines in share prices continue, impairment or valuation losses may arise on investment securities held, affecting our group's performance and potentially reducing its equity ratio.」
The risk of impairment and valuation losses on investment securities held due to falling share prices continues. - FY2019MaterialisedAnnual report
「During the consolidated fiscal year, we recognized impairment losses and recorded a ¥25 million valuation loss on investment securities.」
The risk of impairment and valuation losses on investment securities due to falling share prices and other factors materialized through the recognition of a ¥25 million valuation loss on investment securities. - FY2019-Q2RestatedAnnual report
「If broad-based and substantial declines in share prices continue, impairment or valuation losses may arise on investment securities held, affecting our group's performance and potentially reducing its equity ratio.」
The risk of impairment and valuation losses on investment securities held due to falling share prices continues. - FY2018-Q3RestatedAnnual report
「If broad-based and substantial declines in share prices continue, impairment or valuation losses may arise on investment securities held, affecting our group's performance and potentially reducing its equity ratio.」
The risk of impairment and valuation losses on investment securities held due to falling share prices continues. - FY2018-Q2RestatedAnnual report
「If broad-based and substantial declines in share prices continue, impairment or valuation losses may arise on investment securities held, affecting our group's performance and potentially reducing its equity ratio.」
The risk of impairment and valuation losses on investment securities held due to falling share prices continues. - FY2017-Q3RestatedAnnual report
「If broad-based and substantial declines in share prices continue, impairment or valuation losses may arise on investment securities held, affecting our group's performance and potentially reducing its equity ratio.」
The risk of impairment and valuation losses on investment securities held due to falling share prices continues. - FY2017-Q2RestatedAnnual report
「If broad-based and substantial declines in share prices continue, impairment or valuation losses may arise on investment securities held, affecting our group's performance and potentially reducing its equity ratio.」
The risk of impairment and valuation losses on investment securities held due to falling share prices continues. - FY2017-Q1RestatedAnnual report
「If broad-based and substantial declines in share prices continue, impairment or valuation losses may arise on investment securities held, affecting our group's performance and potentially reducing its equity ratio.」
The risk of impairment and valuation losses on investment securities held due to falling share prices continues. - FY2016First statedAnnual report
「If broad-based and substantial declines in share prices continue, impairment or valuation losses may arise on investment securities held, affecting our group's performance and potentially reducing its equity ratio.」
Changes in the market prices of securities held are identified as a risk that could affect performance and the equity ratio.